lobbying_activities: 1887840
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1887840 | a057d5f2-83cf-4611-a81c-06b536c47f4d | Q3 | KING & SPALDING LLP | 21632 | U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM | 2016 | third_quarter | TOR | Provisions in the Food, Drug & Cosmetic Act related to advertising involving drugs | Congressional Budget Office (CBO) | 0 | 0 | 2016-10-19T14:27:00.357000-04:00 |